Research Projects

Current projects

Showing results 381 - 390 out of 401

1998


Bauer P, Röhmel J, Maurer W, Hothorn L. Testing strategies in multi-dose experiments including active control. Statistics in medicine. 1998 Dec 21;17(18):2133-2146. doi: 10.1002/(SICI)1097-0258(19980930)17:18<2133::AID-SIM901>3.0.CO;2-2
Fairweather WR, Bhattacharyya A, Ceuppens PP, Heimann G, Hothorn LA, Kodell RL et al. Biostatistical methodology in carcinogenicity studies. Therapeutic Innovation & Regulatory Science. 1998 Dec 30;32(2):401-421. doi: 10.1177/009286159803200212, 10.15488/2987
Lalla S, Hothorn LA, Haag N, Bader R, Bauss F. Lifelong administration of high doses of ibandronate increases bone mass and maintains bone quality of lumbar vertebrae in rats. Osteoporosis international. 1998 Mar;8(2):97-103. doi: 10.1007/BF02672503
Ngezahayo A, Zeilinger C, Todt I, Marten I, Kolb HA. Inactivation of expressed and conducting rCx46 hemichannels by phosphorylation. Pflugers Archiv European Journal of Physiology. 1998 Jul;436(4):627-9. doi: 10.1007/s004240050681

1997


Hothorn LA, Martin U. Application of adaptive interim analysis in pharmacology. Therapeutic Innovation & Regulatory Science. 1997 Dec 30;31(2):615-619. doi: 10.1177/009286159703100229, 10.15488/2981
Hothorn LA. Guest editor's note: Biostatistics in preclinical studies. Therapeutic Innovation & Regulatory Science. 1997 Dec 30;31(2):321-322. doi: 10.1177/009286159703100201, 10.15488/3010
Hothorn LA. Modifications of the closure principle for analyzing toxicological studies. Therapeutic Innovation & Regulatory Science. 1997 Dec 30;31(2):403-412. doi: 10.1177/009286159703100211, 10.15488/3022
Hothorn LA, Lin KK, Hamada C, Rebel W. Recommendations for biostatistics of repeated toxicity studies. Therapeutic Innovation & Regulatory Science. 1997 Dec 20;31(2):327-334. doi: 10.1177/009286159703100203, 10.1177/009286159703100203
Kropf S, Hothorn LA, Läuter J. Multivariate many-to-one procedures with applications to preclinical trials. Therapeutic Innovation & Regulatory Science. 1997 Dec 30;31(2):433-447. doi: 10.1177/009286159703100214, 10.15488/3023
Neuhäuser M, Hothorn LA. The control of the consumer risk in the Ames assay. Drug Information Journal. 1997 Dec 30;31(2):363-367. doi: 10.1177/009286159703100207, 10.15488/3052

Finished projects

Showing results 381 - 390 out of 401

1998


Bauer P, Röhmel J, Maurer W, Hothorn L. Testing strategies in multi-dose experiments including active control. Statistics in medicine. 1998 Dec 21;17(18):2133-2146. doi: 10.1002/(SICI)1097-0258(19980930)17:18<2133::AID-SIM901>3.0.CO;2-2
Fairweather WR, Bhattacharyya A, Ceuppens PP, Heimann G, Hothorn LA, Kodell RL et al. Biostatistical methodology in carcinogenicity studies. Therapeutic Innovation & Regulatory Science. 1998 Dec 30;32(2):401-421. doi: 10.1177/009286159803200212, 10.15488/2987
Lalla S, Hothorn LA, Haag N, Bader R, Bauss F. Lifelong administration of high doses of ibandronate increases bone mass and maintains bone quality of lumbar vertebrae in rats. Osteoporosis international. 1998 Mar;8(2):97-103. doi: 10.1007/BF02672503
Ngezahayo A, Zeilinger C, Todt I, Marten I, Kolb HA. Inactivation of expressed and conducting rCx46 hemichannels by phosphorylation. Pflugers Archiv European Journal of Physiology. 1998 Jul;436(4):627-9. doi: 10.1007/s004240050681

1997


Hothorn LA, Martin U. Application of adaptive interim analysis in pharmacology. Therapeutic Innovation & Regulatory Science. 1997 Dec 30;31(2):615-619. doi: 10.1177/009286159703100229, 10.15488/2981
Hothorn LA. Guest editor's note: Biostatistics in preclinical studies. Therapeutic Innovation & Regulatory Science. 1997 Dec 30;31(2):321-322. doi: 10.1177/009286159703100201, 10.15488/3010
Hothorn LA. Modifications of the closure principle for analyzing toxicological studies. Therapeutic Innovation & Regulatory Science. 1997 Dec 30;31(2):403-412. doi: 10.1177/009286159703100211, 10.15488/3022
Hothorn LA, Lin KK, Hamada C, Rebel W. Recommendations for biostatistics of repeated toxicity studies. Therapeutic Innovation & Regulatory Science. 1997 Dec 20;31(2):327-334. doi: 10.1177/009286159703100203, 10.1177/009286159703100203
Kropf S, Hothorn LA, Läuter J. Multivariate many-to-one procedures with applications to preclinical trials. Therapeutic Innovation & Regulatory Science. 1997 Dec 30;31(2):433-447. doi: 10.1177/009286159703100214, 10.15488/3023
Neuhäuser M, Hothorn LA. The control of the consumer risk in the Ames assay. Drug Information Journal. 1997 Dec 30;31(2):363-367. doi: 10.1177/009286159703100207, 10.15488/3052